Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 14.5.2024Zentiva, k.s. (ZNT-1)02829Triamcinolon Léčiva ung (ung der 1x10 g (tuba Al))17.5.2024O
 14.5.2024Zentiva, k.s. (ZNT-1)2517DZetovar 10 mg/80 mg tablety (tbl 90x10 mg/80 mg (blis.OPA/Al/PVC))15.5.2024O
 14.5.2024Zentiva, k.s. (ZNT-1)03575Heparoid Léčiva (crm der 1x30 g (tuba Al))17.5.2024O
 14.5.2024Zentiva, k.s. (ZNT-1)0567BOzzion 40 mg gastrorezistentné tablety (tbl ent 98x40 mg (blis.nylon/Al/PVC/Al))15.5.2024O
 14.5.2024Zentiva, k.s. (ZNT-1)4974DSorafenib Zentiva (tbl flm 112x1x200 mg (blis.Al/PVC/PE/PVDC-jednotliv.dáv.))15.5.2024O
 14.5.2024Zentiva, k.s. (ZNT-1)0902DCornusan 10 mg/20 mg (tbl 100x10 mg/20 mg (blis.OPA/Al/PVC/Al))20.5.2024O
 14.5.2024Zentiva, k.s. (ZNT-1)81830Valzap HCT 160 mg/12,5 mg (tbl flm 28x160 mg/12,5 mg (blis.PVC/PE/PVDC/Al))15.5.2024O
 14.5.2024Zentiva, k.s. (ZNT-1)2516DZetovar 10 mg/80 mg tablety (tbl 30x10 mg/80 mg (blis.OPA/Al/PVC))15.5.2024O
 14.5.2024Zentiva, k.s. (ZNT-1)0901DCornusan 10 mg/20 mg (tbl 30x10 mg/20 mg (blis.OPA/Al/PVC/Al))15.5.2024O
 14.5.2024GlaxoSmithKline (Ireland) Limited (GAG-IE-2)13971Flixotide 50 Inhaler N (sus inh 1x120 dávok (nád.tlak.Al))14.5.2024R
 14.5.2024Pfizer Europe MA EEIG (PFI-BE-3)93860DIFLUCAN 150 mg (cps dur 1x150 mg (blis.PVC/Al-priehľ.))15.7.2024R
 13.5.2024Teva B.V. (TEV-NL-4)83244Talopam 25 mg (tbl flm 60x25 mg (blis.Al/Al))13.5.2024O
 13.5.2024Teva B.V. (TEV-NL-4)83256Talopam 50 mg (tbl flm 60x50 mg (blis.Al/Al))13.5.2024O
 13.5.2024TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)3270BPramipexol Teva Pharma 0,52 mg (tbl plg 30x0,52 mg (blis.OPA/Al/PVC/Al))13.5.2024O
 13.5.2024MERCK spol. s r.o. (MRS)91974Euthyrox 125 mikrogramov (tbl 100x125 µg (blis.PVC/Al))13.5.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To